Cardiff Oncology (CRDF) Change in Acquisitions & Divestments (2016 - 2025)

Cardiff Oncology has reported Change in Acquisitions & Divestments for 8 years, with the latest figure at $899000.0 in Q4 2025.

• Quarterly Change in Acquisitions & Divestments fell 94.66% year-over-year to $899000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.1 million (down 92.12% YoY) and the FY2025 annual result came in at $2.1 million, down 92.12% from the prior year.
• Change in Acquisitions & Divestments rose to $899000.0 in Q4 2025 per CRDF's latest filing, from -$20.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $43.0 million in Q1 2023 and troughed at -$20.0 million in Q2 2025.
• A 5-year average of $11.6 million and a median of $12.3 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2022 and 2025: Change in Acquisitions & Divestments jumped 584.22% in 2022, then plunged 391.0% in 2025.
• Over 5 years, Change in Acquisitions & Divestments stood at $13.3 million in 2021, then grew by 14.49% to $15.2 million in 2022, then tumbled by 60.45% to $6.0 million in 2023, then jumped by 179.84% to $16.8 million in 2024, then plunged by 94.66% to $899000.0 in 2025.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $899000.0, -$20.0 million, and $21.2 million for Q4 2025, Q2 2025, and Q1 2025 respectively.